Dosing & Administration

Share / Send / Save

Powerful, portable, on-demand therapy for your patient’s acute HAE attacks

For patients 18 years of age and older with HAE, FIRAZYR is indicated for the treatment of acute HAE attacks.

  • After receiving training from a healthcare professional, your patients may self-administer FIRAZYR upon recognition of symptoms of an HAE attack.

FIRAZYR administration

FIRAZYR is available as a 3 mL, prefilled, single-use syringe (30 mg). It requires no reconstitution, dose calculation, dose titration or refrigeration. Store FIRAZYR between 36°F and 77°F (2°C and 25°C). Syringes are available in cartons of 1 or 3 syringes.

FIRAZYR is administered as a slow, subcutaneous injection into the abdominal area over at least 30 seconds.

  • If response is inadequate or symptoms recur, additional doses may be administered at intervals of at least 6 hours.
  • No more than 3 doses may be administered in a 24-hour period.

FIRAZYR® (icatibant injection) product packaging photo